Our technology research center is born with the calling
of boosting and preserving ARQUIMEA Group and
its companies’ innovative nature.
Its mission is to provide the Group’s brands with capacity
of implementing the R&D projects they carry out.
We grow our business with the acquisition of RAMEM,
specialized in industrial design and making, and AMERICA, whose activity is focused on
assembling and maintenance of electric railway installations.
At the beginning of the health crisis prompted by COVID19,
we found Alianza Covid19,
a consortium of Spanish genetic diagnosis labs
that produce PCR and ELISA tests to detect coronavirus.
We start ARQUIMEA Medical, our healthtech business unit.